Evidence map›Paper›PMID 36294720›Full record

ArticleJournal of personalized medicine2022

Communicating Personal Melanoma Polygenic Risk Information: Participants' Experiences of Genetic Counseling in a Community-Based Study.

Amelia K Smit, David Espinoza, Georgina L Fenton, Judy Kirk, Jessica S Innes, Michael McGovern, Sharne Limb, On Behalf Of The Managing Your Risk Study Group, Erin Turbitt, Anne E Cust

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. GP perspectives on genomics in primary care: a qualitative study on using polygenic risk scores to evaluate cancer risk.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Amelia K SmitThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney 2000, Australia.ORCID 0000-0001-5712-220X
David EspinozaNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney 2000, Australia.
Georgina L FentonThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney 2000, Australia.
Judy KirkWestmead Clinical School and Westmead Institute for Medical Research, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney 2000, Australia.
Jessica S InnesDiscipline of Genetic Counselling, Graduate School of Health, University of Technology Sydney, Sydney 2000, Australia.
Michael McGovernMaastricht University, 6221 BS Maastricht, The Netherlands.ORCID 0000-0003-3405-2151
Sharne LimbParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospitals, Melbourne 3000, Australia.
On Behalf Of The Managing Your Risk Study Group
Erin TurbittDiscipline of Genetic Counselling, Graduate School of Health, University of Technology Sydney, Sydney 2000, Australia.ORCID 0000-0002-6650-9702
Anne E CustThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney 2000, Australia.ORCID 0000-0002-5331-6370
The University of Sydney · AUUniversity of Technology Sydney · AUMaastricht University · NLThe Royal Melbourne Hospital · AU

Funding

National Health and Medical Research Council AEC was funded by fellowships from the NHMRC (1147843 and 2008454)National Health and Medical Research Council project grant (1129822)University of Sydney AKS received a Research Training Program (RTP) Stipend Scholarship and a Merit Top Up Scholarship from the University of Sydney, and a Melanoma Institute Australia Postgraduate Research Scholarship
6 · The paper itself

Abstract

Personalized polygenic risk information may be used to guide risk-based melanoma prevention and early detection at a population scale, but research on communicating this information is limited. This mixed-methods study aimed to assess the acceptability of a genetic counselor (GC) phone call in communicating polygenic risk information in the Melanoma Genomics Managing Your Risk randomized controlled trial. Participants (

Indexed as

genetic counselingmelanomapolygenic risk scoreprecision medicinerisk communication

Identifiers

PMID36294720
PMCPMC9605561
OpenAlexW4297225110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.